NCT00285623View on ClinicalTrials.gov

Observational Cohort Study of TachoSil (TC-018-IN)

CompletedOBSERVATIONAL

Enrollment

3,000

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

July 31, 2008

Conditions

Blood Loss, Surgical

Interventions

DRUG

Fibrinogen (human) + thrombin (human) (TachoSil)

treatment in surgery for improvement of haemostasis where standard techniques are insufficient

Trial Locations (1)

4000

Nycomed, Roskilde

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Nycomed

INDUSTRY